Uppsala, Sweden July 12, 2011 – Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical, medicinal, and peptide chemistry, introduced an innovative, new instrument for peptide professionals at the 2011 American Peptide Symposium in San Diego, California USA.
The Biotage Initiator+ SP Wave is a versatile synthesis solution as it can be used as a standalone peptide synthesizer or easily converted to a high specification MAOS system. It is the ideal development tool for chemists synthesizing peptides, peptidomimetics and small molecules using single or multi-step procedures.
The Initiator+ SP Wave is perfectly suited for the small scale synthesis of peptides and peptidomimetics including PNA using microwave irradiation, from a scale as low as 5 µmol. The semi-automated operation can reduce the consumption and waste of expensive reagents which occur in other systems due to priming or use of large dead volumes.
The Initiator+ SP Wave is a semi-automated, programmable synthesis system. It includes a large 10” touch screen, intuitive software, pre- or self-defined methods, inert gas capability, vortex and magnetic stirring.
“As the global leader in the development of technology for peptide synthesis, Biotage continues to develop tools for professionals demanding excellent purity, reliability and high yield.” says Toshiyuki Yachi, Vice President of Marketing. “With the recent introduction of the Initiator Peptide Workstation and Syro Wave, Biotage now offers a manual, semi-automatic and fully automatic peptide synthesis solution including resins and HPLC columns. Biotage is clearly the dedicated leader in providing solutions for peptide professionals.”
Biotage is the only manufacturer of traditional, room temperature peptide synthesizers as well as microwave peptide synthesizers in both entry-level and high throughput configurations. For more information on the Biotage Initiator+ SP Wave system, please email firstname.lastname@example.org or visit www.biotage.com/peptides
For further press information at Biotage please contact: Rob Thompson, Director of Marketing Communications, 10430 Harris Oaks Blvd., Suite C, Charlotte, NC USA 28269 Tel: +1 704 654 4847 Fax: +1 704 654 4917 Email: email@example.com
Biotage offers solutions, knowledge and experience in the areas of analytical, medicinal and peptide chemistry. The customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 272 employees and had sales of 428.9 MSEK in 2010. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.
Determination of Diquat and Paraquat in Drinking Water - New Application Note
Extraction of THC and its Metabolites from Human Nails - New Application Note
New Method for Determination of Voriconazole in Plasma
Biotage Receives the SwedenBIO Award 2019
New Method for Determination of 1, 4-Dioxane in Drinking Water